Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide

Akiko Hashimoto; Yasuhiro Tanaka; Takayuki Ishikawa; Isaku Shinzato

doi:10.1002/ccr3.4417

Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide

Clin Case Rep. 2021 Jul 23;9(7):e04417. doi: 10.1002/ccr3.4417. eCollection 2021 Jul.

Authors

Akiko Hashimoto¹, Yasuhiro Tanaka¹, Takayuki Ishikawa², Isaku Shinzato¹

Affiliations

¹ Department of Hematology and Clinical Immunology Kobe City Nishi-Kobe Medical Center Kobe Japan.
² Department of Hematology Kobe City Hospital Organization Kobe City Medical Center General Hospital Kobe Japan.

Abstract

A man with chronic kidney disease (CKD) under hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide (ATO) can be used safely and effectively for APL with CKD.

Keywords: ATO; acute promyelocytic leukemia; chronic kidney disease.

Publication types

Case Reports